arrow
M

Makoto Ueno

kanagawa cancer center
H指数:45
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Preoperative prognostic stratification of high-risk resectable pancreatic cancer: combined Podxl/itgb1 expression in EUS-FNAB specimens as a prognostic biomarker

术前高危可切除胰腺癌的预后分层:EUS-FNAB标本中Podxl/itgb1联合表达作为预后生物标志物

2026-10-020
OAAI
Validation of novel scoring systems for acute decompensated cirrhosis identifies PBC as an independent poor prognostic factor: a single-center Japanese cohort study

新型急性失代偿性肝硬化评分系统的验证识别PBC为独立的不良预后因素:一项日本单中心队列研究

2025-10-120
PRE
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with pancreatic cancer

泛亚洲适应性ESMO临床实践指南:胰腺癌患者的诊断、治疗和随访

2025-10-090
OAAI
Multicenter Retrospective Study of Efficacy of Systemic Therapy in Patients with Neuroendocrine Tumor Grade 3 (JOSC-2001)

多中心回顾性研究:系统性疗法在神经内分泌肿瘤3级患者中的疗效(JOSC-2001)

2025-09-010
PRE
Outcomes of FOLFIRINOX versus Gemcitabine plus nab-Paclitaxel in Patients with Early Recurrent Pancreatic Cancer after Adjuvant S-1 Treatment: A propensity Score-matched Analysis

FOLFIRINOX与吉西他滨联合nab-紫杉醇在S-1辅助治疗后早期复发性胰腺癌患者中的疗效比较:一项倾向性评分匹配分析

2025-08-300
PRE
Electronic Patient-Reported Outcome Quality of Life Score in Japanese Patients With Pancreatic Cancer on Second-Line Chemotherapy: A Multicenter Observational Study

电子患者报告结局生活质量评分在日本胰腺癌二线化疗患者中的研究:一项多中心观察性研究

2025-08-260
OAAI
Clinical importance of suspicious for malignancy compared to positive for malignancy in peritoneal cytology for surgically resected pancreatic cancer

与手术切除的胰腺癌腹腔细胞学中的“阳性恶性”相比,“可疑恶性”的临床重要性

2025-05-240
OA
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer (vol 9, 103647, 2024)
2025-01-010
OAAI
Efficacy and safety in the KEYNOTE-966 study of pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) for advanced biliary tract cancer (BTC): Impact of hepatitis B virus (HBV) infection

KEYNOTE-966研究评估帕博利珠单抗(pembro)联合吉西他滨和顺铂(gem/cis)治疗晚期胆道癌(BTC)的疗效与安全性:乙型肝炎病毒(HBV)感染的影响

2024-12-011
PRE
Prognostic nutritional index is an independent risk factor for continuing S-1 adjuvant chemotherapy in patients with pancreatic cancer who received neoadjuvant chemotherapy and surgical resection
2024-11-291
OAAI
5-Fluorouracil metabolic pathway genes predict recurrence risk following adjuvant S-1 therapy: Results of an ancillary analysis from a phase III trial of resected biliary tract cancer (JCOG1202A1)
2024-09-250
PRE
Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after FOLFIRINOX or gemcitabine plus nab-paclitaxel chemotherapy: A multicenter retrospective cohort study (PC-CURE-1)
2024-08-161
OA
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer

泛亚适应ESMO临床实践指南,用于胆道癌患者的诊断,治疗和随访

2024-08-010
OAAI
The SCRUM-MONSTAR Cancer-Omics Ecosystem: Striving for a Quantum Leap in Precision Medicine

Scrum-monstar癌症组学生态系统: 努力实现精准医学的飞跃

2024-07-161
OAAI